Rejoinder: Arsenic exposure and prevalence of type 2 diabetes updated findings from the national health nutrition and examination survey, 2003-2006

Epidemiology

Volumn 20, Issue 6, 2009, Pages 816-820

  Navas Acien, Ana ^a,b   Silbergeld, Ellen K ^a   Pastor Barriuso, Roberto ^c,d   Guallar, Eliseo ^b,e,f  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CARLOS III INSTITUTE OF HEALTH   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^f DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; ARSENOBETAINE; ARSENOCHOLINE;

CALCULATION; ENVIRONMENTAL EXPOSURE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; URINALYSIS;

ADULT; ARSENIC; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; NUTRITION SURVEYS; RISK ASSESSMENT; UNITED STATES; YOUNG ADULT;

EID: 74549128506     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181afef88     Document Type: Short Survey

References (21)

1. Ettinger AS, Zota AR, Amarasiriwardena CJ, et al. Maternal arsenic exposure and impaired glucose tolerance during pregnancy. Environ Health Perspect. 2009;117:1059-1064.
2. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA. 2008;300:814-822.
3. Andrew AS, Jewell DA, Mason RA, Whitfield ML, Moore JH, Karagas MR. Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a US population. Environ Health Perspect. 2008;116:524-531.
4. Chen Y, Parvez F, Gamble M, et al. Arsenic exposure at low-tomoderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol Appl Pharmacol. 2009 Jan 26. [Epub ahead of print.]
5. Paul DS, Harmon AW, Devesa V. Thomas DJ, Styblo M. Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Environ Health Perspect. 2007;115:734-742. (Pubitemid 46785043)
6. Pysher MD, Sollome JJ, Regan S. et al. Increased hexokinase II expression in the renal glomerulus of mice in response to arsenic. Toxicol Appl Pharmacol. 2007;224:39-48. (Pubitemid 47404619)
7. Straub AC. Stolz DB, Vin H, et al. Low level arsenic promotes progressive inflammatory angiogenesis and liver blood vessel remodeling in mice. Toxicol Appl Pharmacol. 2007;222:327-336. (Pubitemid 47198271)
8. Straub AC. Clark KA, Ross MA, et al. Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide. J Clin Invest. 2008;118:3980-3989.
9. Francesconi KA, Kuehnelt D. Determination of arsenic species: a critical review of methods and applications. 2000-2003. Analyst. 2004;129:373-395.
10. Hughes MF. Biomarkers of exposure: a case study with inorganic arsenic. Environ Health Perspect. 2006;14:1790-1796. (Pubitemid 44718288)
11. Navas-Acien A, Guallar E. Measuring arsenic exposure, metabolism, and biological effects: the role of urine proteomics. Toxicol Sci. 2008;106:1-4.
12. National Center tor Environmental Health. Laboratory procedure manual. Total arsenic. 2008. Available at: http://0-www.cdc.gov.pugwash.lib.waiwick.ac. uk/nchs/data/nhanes/nhanes-03-04/106uas-c- met arsenic tol.al.pdf. Accessed May 11, 2009.
13. National Center for Environmental Health. Laboratory procedure manual. Urine arsenic species. 2008. Available at: http://www.cdc.gov/nchs/data/nhanes/ nhanes-03-04/l06uas-c-met-arsenic-specialed.pdf. Ac cessed May 11. 2009.
14. Caldwell KL, Jones RL, Verdon CP, Jarrett JM. Caudill SP, Osterloh JD. Levels of urinary total and speciated arsenic in the US population:National Health and Nutrition Examination Survey 2003-2004.J Expo Sci Environ Epidemiol. 2009:19:59-68.
15. Steinmaus C, Yuan Y, Liaw J, Smith AH. Low level population exposure to inorganic arsenic in the United States and diabetes mellitus. Epidemiology. 2009;20:656-664.
16. Coronado-Gonzalez JA, Del Razo LM, Garoia-Vargas G, SanmiguelSalazar F, Escobedo-de la Peña J. Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico. Environ Res. 2007;104:383 389. (Pubitemid 46856360)
17. World Health Organization. Guidelines for Drinking-Water Quality. 3rd ed. Geneva: World Health Organization; 2003.
18. National Research Council. Arsenic in Drinking Water. Washington, DC: National Academy Press: 1999.
19. Navas-Acien A, Umans JG, Howard BV, et al. Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period. The Strong Heart Study. Environ Health Perspect. 2009;Epub May 7, 2009. doi:10.1289/ehp.0800509.
20. Chen YC, Amarasiriwardena CJ, Hsueh YM, Christiani DC. Stability of arsenic species and insoluble arsenic in human urine. Cancer Epidemiol Biomarkers Prev. 2002;11:1427-1433. (Pubitemid 35340380)
21. Hall M, Gamble M, Slavkovich V, et al. Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin. and homocysteine concentrations in maternal-newborn pairs. Environ Health Perspect. 2007:115:1503-1509. (Pubitemid 47618094)